Companies / Santa Cruz Biotechnology / Cdk5 (J-3) FITC
Santa Cruz Biotechnology

Cdk5 (J-3) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG2b; Cdk5 Antibody (J-3) is an IgG2b κ mouse monoclonal Cdk5 antibody (also designated cyclin dependent kinase 5 antibody or PSSALRE antibody) that detects the Cdk5 protein of mouse, rat and human origin by WB, IP, IF and ELISA. Cdk5 Antibody (J-3) is available as both the non-conjugated anti-Cdk5 antibody form, as well as multiple conjugated forms of anti-Cdk5 antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Cell cycle progression is controlled in part by a family of cyclin proteins and cyclin dependent kinases (Cdks). Cdk proteins work in concert with the cyclins to phosphorylate key substrates involved in each phase of cell cycle progression. Another family of proteins, Cdk inhibitors, also plays a role in regulating cell cycle by binding to cyclin-Cdk complexes and modulating their activity. Several Cdk proteins have been identified, including Cdk2-Cdk8, PCTAIRE-1-3, PITALRE and PITSLRE. Cdk5 is thought to be involved in the G1-S transition of the cell cycle and is highly expressed in mature neurons. Activity of Cdk5 increases significantly during neuronal differentiation. Cdk5 has been postulated to be a neurofilament or tau protein kinase, based on its ability to phosphorylate these proteins in vitro.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.